Caregiver Stress and Sleep Study
CARES
2 other identifiers
interventional
120
1 country
1
Brief Summary
This study includes a randomized experimental component where therapists will systematically deliver an experimental behavioral probe or a supportive control condition. The aim is to evaluate effects on meaningful health-relevant measures including morning activation levels, depression symptoms, rumination, and aspects brain connectivity previously linked with depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2022
CompletedFirst Posted
Study publicly available on registry
February 2, 2022
CompletedStudy Start
First participant enrolled
July 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 10, 2025
July 1, 2025
3.9 years
January 21, 2022
July 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Change from baseline in rumination at 6-months
Rumination will be measured using the rumination subscale of the Behavioral Activation Scale for Depression (BASD). There is a minimum possible score of 0 and a maximum possible score of 24 with higher scores indicating higher \[worse\] rumination. This measure will be accessed via Ecological Momentary Assessment (EMA). A link will be sent to participant's mobile device by text message cuing participants to respond
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change from baseline in depressive symptoms at 6-months
Depression will be measured using the Patient Health Questionnaire (PHQ-9). There is a minimum possible score of 0 and a maximum possible score of 27 with higher scores indicating higher \[worse\] depression.
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change from baseline in anxiety symptoms at 6-months
Anxiety will be measured using the Generalized Anxiety Disorder 7-Item Scale (GAD-7). There is a minimum possible score of 0 and a maximum possible score of 21 with higher scores indicating higher \[worse\] anxiety.
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change in objective Morning Activation Deficits (MADs) over 1 week
Morning activation deficits (MADs), a common component of depression measurable as actigraphy assessed morning inactivity.
Continuously for up to 1-week at baseline
Change in self-report Morning Activation Deficits (MADs) at 6-months
Morning Activation Deficits (MADs) will be assessed using the Composite Morningness Questionnaire (CMQ). There is a minimum possible score of 13 and a maximum possible score of 55 with higher scores indicating a higher degree or morningness.
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change in resting-state connectivity at 6-weeks
Resting connectivity of the amygdala and ventral posterior cingulate cortex (PCC) structures will be measured by brain imaging conducted with a 7 Tesla scanner
Baseline and 6-weeks
Change in neurological response to rumination cues at 6 weeks
Rumination-related brain activation in the Limbic (amygdala), default mode network (DMN), ventral posterior cingulate cortex (PCC), and Frontal Parietal Control Network (FPCN) will be measured by brain imaging conducted with a 7 Tesla scanner.
Baseline and 6-weeks
Secondary Outcomes (7)
Change in self-report nocturnal mentation at 6-months
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change in self-report reward anticipation at 6-months
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change in self-report apathy at 6-months
Baseline, continuously up to weekly for 6-weeks, and follow-up (6 months)
Change in morning light exposure at 6-weeks
Baseline and 6-weeks
Change in cognitive functioning at 6-weeks
Baseline and 6-weeks
- +2 more secondary outcomes
Study Arms (2)
Active condition (SAMM Protocol)
EXPERIMENTALThe goal of the SAMM protocol is to increase morning activity engagement over a 6-week period. Participants in this condition will review their morning routine, and make a list of potential morning activities to add. They will choose one activity and develop a plan for doing it. Each day, participants are asked to track if they do the morning activity plan. If unsuccessful, at weekly follow-ups, participants are asked to refine their plan or make a new one.
Attention-matched supportive control condition
ACTIVE COMPARATORParticipants in this condition will receive sessions in the same number and duration as the SAMM experimental condition. Therapists will create a comfortable environment by demonstrating interest, empathy, and acceptance without judgment. Caregivers will be encouraged to talk about stressors they experience, providing an opportunity to voice and self-address their problems. In this control condition, therapists will not deliver any particular strategy except for active listening and referring to the educational materials.
Interventions
Each day, participants are asked to track if they do the morning activity plan.
Participants will meet weekly with a trained therapist to discuss their prescribed activity plan. If unsuccessful, at weekly follow-ups, participants are asked to refine their plan or make a new one. Each session lasts about 30-45 minutes.
Participants will meet weekly with trained a therapist to talk about stressors they experience, providing an opportunity to voice and self-address their problems. In this control condition, therapists will not deliver any particular strategy except for active listening and referring to the educational materials
Some participants will be asked to adjust their sleep schedule to accommodate morning activity engagement by introducing or altering mechanisms known promote early rising (i.e., light exposure, reward and processes, etc.)
Eligibility Criteria
You may qualify if:
- Age 60 years or older.
- Provide at least 15 hours/week of unpaid care to a patient with a dementia diagnosis.
- Reporting stress or strain delivering care
- No or stable pharmacotherapy for depression
- Meets screening definition for having morning activation difficulty or a definite morning types per the Composite Morningness Questionnaire (CMQ)
You may not qualify if:
- Unsafe or unable to undergo MRI
- Active Cognitive Behavioral Therapy for mood or insomnia
- Probable dementia diagnosis
- Deadly illness or plans to leave the study area
- Current active substance use disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UPMC Western Behavioral Health
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen F Smagula, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychiatry
Study Record Dates
First Submitted
January 21, 2022
First Posted
February 2, 2022
Study Start
July 15, 2022
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 10, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share